patent.fyi
Applications  /  US 2026/0355179
United States Patent Application Publication

US 2026/0355179 A1

Published
Nov 12, 2026
Filed
Oct 30, 2023
Earliest date on the face
Oct 31, 2022
Classification
A61K 31/496
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

No entries.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Reference inhibitor for cell assay calibration

A cell assay development laboratory uses the pyridine derivative as a reference inhibitor in a plate assay with cells that express TRPV1. Wells contain a calcium-sensitive fluorescent dye and receive either the derivative in a solvent or the solvent alone. Capsaicin activates the channel, and the difference in peak fluorescence between the two groups measures inhibition under the assay conditions.

Component substitution

Cellulose filler in an oral capsule

A hard capsule containing the pyridine derivative uses microcrystalline cellulose in place of lactose as the diluent. The active powder is blended with a small portion of the cellulose, and successive additions of cellulose distribute the active powder through the batch. A capsule filler meters the blend into shells, and samples from the filled batch are assayed for active content.

Parameter or scale variation

Concentration series for measuring channel inhibition

A 96-well assay plate holds cells that express TRPV1 and a calcium-sensitive fluorescent dye, with eight test concentrations of the pyridine derivative in triplicate. The series starts at 10 micromolar and uses successive threefold dilutions, with the same final solvent fraction in each well. After a 10-minute preincubation, capsaicin is added and the peak fluorescence is recorded over 60 seconds. A concentration-response curve is fitted to the peak responses relative to the solvent controls.

Combination with existing systems

Drug delivery within a skin permeation cell

A hydrogel containing the pyridine derivative is placed on the outer surface of an excised skin sample clamped between the donor and receiver chambers of a vertical diffusion cell. The receiver contains a stirred, temperature-controlled fluid selected to maintain sink conditions for the derivative. Receiver samples collected at fixed intervals are analyzed by liquid chromatography, and their concentrations are used to calculate cumulative permeation per unit area with a correction for sampled fluid.

Channel inhibition in a patch clamp system

A whole-cell patch clamp system records membrane current from a cell that expresses TRPV1 while a multichannel perfusion manifold switches the solution around the cell. The manifold delivers recording buffer, capsaicin in buffer, and capsaicin with the pyridine derivative at the same solvent fraction. The recording compares peak capsaicin-evoked currents during vehicle and derivative exposure, and repeated vehicle pulses measure current loss during the recording.

Automated or data-driven variant

Automated scoring of reciprocal social interaction

An overhead camera records pairs of individually marked animals in a preclinical study with pyridine derivative and vehicle groups. Pose estimation software tracks each animal's nose and body center and flags frames in which either track is lost. A scoring script uses nose-to-body distance and heading to identify approach and contact bouts, then aggregates bout counts and durations by pair and treatment group.

Cite aspatent.fyi, US 2026/0355179 A1, claim 1, first published 2026-11-19T09:07:06-05:00, https://patent.fyi/US20260355179/, SHA-256 d4a21cb0a5a1adece03baa4d743235cefab60f68bc248dcbbcef4bb286d19c40
First published
Permanent addresshttps://patent.fyi/US20260355179/
Content fingerprint (SHA-256)d4a21cb0a5a1adece03baa4d743235cefab60f68bc248dcbbcef4bb286d19c40
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi